Novo Nordisk Advances Share Buyback Program

Novo Nordisk (NVO) has released an update.

Novo Nordisk A/S, a leader in global healthcare, has been actively executing a share repurchase program, buying back B shares as part of a larger DKK 20 billion repurchase initiative set to span 12 months starting from February 2024. By October 4, 2024, the company had repurchased 12,896,648 B shares at an average price of DKK 879.22 each, amounting to a transaction value of DKK 11,339,024,603. This move reflects Novo Nordisk’s continued investment in its own equity, underscoring the company’s financial strategies and commitment to shareholder value.

For further insights into NVO stock, check out TipRanks’ Stock Analysis page.